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Objectives: The aims of the study are to determine the antimicrobial and antibiofilm activities of M. alba leaves 
extract against Streptococcus mutans (S.mutans). Method: The antimicrobial activity was evaluated using 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The antibiofilm 
potential of extract was evaluated using biofilm inhibition assay and biofilm eradication assay. Oradex 
mouthwash with 0.12% CHX was used as a positive control. All experiments were performed in triplicate and 
repeated four times independently. Data were analysed using SPSS software version 23. A Kruskal-Wallis test 
followed by post-hoc Mann-Whitney U test was applied and level of significance was set at P < 0.001.  Results: 
Morus alba (M.alba) leaves extract showed antimicrobial activity against S.mutans with MIC and MBC, 
25mg/ml and 50mg/ml respectively. The adherence of bacteria on extract treated surface (0.5x MIC) was 
significantly reduced with adherence inhibition percentage of 72.5% compared to positive control CHX 0.12% 
(63%).  At 0.5x MIC concentration, the extract also disrupted preformed biofilms with eradication percentage of 
52.87%.  Conclusion: The results suggest that M. alba leaves extract represents an untapped source of local 
plant with antibiofilm activity against S.mutans that could be a resource in the development of therapeutic 
natural products in managing dental caries.  
1. Introduction 
Dental caries (tooth decay) is a transmissible bacterial 
disease process caused by the acid released from the 
acidogenic bacteria which enters the enamel and dentine 
and dissolving the mineral [1]. Dental caries attacks all 
ages including school-age children and adults. In 
Malaysia, the prevalence of dental caries among 5 and 6-
year-old children was reported to be 76.2% and 74.5%, 
respectively [2,3]. Higher caries prevalence (90.3%) was 
also recorded among adult in Malaysia from the age of 
15 and above [4]. It is also the main cause of oral pain 
and tooth loss, which will lead to difficulty in chewing, 
speech problems, general health disorder and affects the 
quality of life [5]. The existence of dental caries is 
mainly associated with oral pathogens, especially 
cariogenic bacteria [6].   
The oral cavity contains a wide variety of oral bacteria, 
but only a few specific species of bacteria are believed to 
cause dental caries which are Streptococcus mutans, 
Lactobacillus acidophilus, Actinomyces viscosus and 
Nocardia sp. [7]. The major role in prognosis and 
development of the oral disease is played by 
Streptococcus mutans. Thus, preventive therapy for 
dental caries will be the elimination of Streptococcus 
mutans [8]. The ability of Streptococcus mutans to 
produce a large quantity of glucans as well as acid, 
exceeding salivary buffering capacities, which gives the 
bacteria an advantage to outcompete noncariogenic 
commensal species at low pH environment [9]. 
Therefore, in our study, we used S. mutans because it is 
one of the most important pathogens involved in the 
formation of dental plaque and its prognosis to dental 
caries [8]. 
Nowadays, researchers are keen to investigate the 
therapeutic agents originated from a natural source such 
as plant extract or plant active compounds which give 
the same effects as the commercial drugs but with lesser 
side effects that are safer for the user. Medicinal plants 
still play an important role in some emerging and 
developing countries and are the major components of 
all indigenous or alternative system of medicine [10].  
Morus is a genus of flowering plants in the family 
Moraceae. Its dried leaves have been consumed as herb-
tea beverage and food supplements [11]. It was reported 
that M.alba leaves were chewed for toothache treatment 
to prevent further destruction or cavitation of the tooth 
[12]. Various pharmacology activities were reported for 
M.alba leaves extract such as antidiabetic activity 
against diabetes mellitus [13]. M. alba also provides 
potential antimicrobial activity against pathogenic 
microorganisms [14]. In addition, subacute toxicity and 
genotoxicity studies reveal that M.alba is significantly 
not toxic and considered safe [15]. The antibiofilm 
potentials of M.alba leaves were reported in few 
studies[16,17].  However, in all the studies, the extract 
was incubated with the bacteria for 18-24 h which do not 
fit the clinical application. In the clinical setting, the 
drugs (oral rinse/gel/paste) are only exposed to the 
teeth/oral cavity in a short period during the 
treatment/application. Thus our objectives in this study 
are to determine antibiofilm potential (initial adherence 
inhibition and biofilm eradication) of M.alba leaves 
extract against S.mutans in short exposure treatment.  
2. Methods 
2.1 Preparation of Extract 
M.alba leaves extract was prepared following the 
methodology proposed by Sánchez et al. 2010, with 
minor modifications [18].  
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2.2 Determination of Minimum Inhibitory 
Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC).  
The MIC and MBC tests were performed in BHI broth 
(BHIB) via broth microdilution techniques according to 
Clinical and Laboratory Standards Institute (CLSI, 2012) 
[19].  
2.3 Determination of Biofilm Inhibition  
The plant extract at subMIC concentrations was 
evaluated for their inhibition potential against cell 
attachments according to the method described by 
Bazargani et al., 2016 [20]. The percentage of biofilm 
formation inhibition was calculated using the following 
formula : 
 
Inhibition 
(%) = 
OD negative control-OD test/ OD negative 
control 
X 100 
 
2.4 Determination Eradication of Biofilm 
The eradication of biofilm formation of the extract was 
performed according to methods described by Bazargani 
et al., 2016 [20]. Percentage of biofilm eradication was 
calculated by using the following equation. 
 
Eradication 
(%)   
= 1  
- 
OD negative control-OD test/ OD negative 
control 
3. Results  
3.1. Minimum Inhibitory Concentration and 
Minimum Bactericidal Concentration 
The antimicrobial activity of M. alba leaves extract 
against S. mutans showed minimum inhibitory 
concentration (MIC) of 25mg/mL and minimum 
bactericidal concentration (MBC) of 50mg/mL. 
 
3.1 Biofilm Inhibition Assay 
Figure 1 shows, the adherence inhibition percentage of 
S.mutans on extract- treated surface . Percentage of 
biofilm inhibition by M. alba extracts is 72.5% whereas 
for biofilm treated with CHX 0.12% is 63%.   
 
3.2 Biofilm Eradication Assay 
Based on the result as shown in Figure 2, the biofilm 
eradication activities of M. alba leaves extract against S. 
mutans biofilm upon 5 minutes treatment was 
concentration- dependent. The percentage increased 
from 40.7% at concentration 6.25 mg/ml to 52.87% at 
12.5 mg/ml. Exposure to Oradex mouthwash (CHX) had 
exhibited 50.54% biofilm eradication.  
 
 
Figure 1: Percentage of biofilm inhibition after treated with M. 
alba extracts at 3.125 mg/ml, 6.25 g/ml, 12.5 mg/ml 
concentrations and CHX 0.12%. The overall percentage of 
biofilm obtained from 4 sets experiments in triplicate (n=12) is 
presented in a bar graph. * indicates significant differences in 
mean percentages were compared to the untreated control 
(p<0.001) according to the non-parametric Kruskal Wallis test 
with Mann Whitney.Different letters indicate statistically 
significant differences between group. 
 
 
 
Figure 2: Percentage of biofilm eradication after treated with 
M. alba extracts at 3.125 mg/ml, 6.25 mg/ml, 12.5 mg/ml 
concentrations and CHX 0.12%. The overall percentage of 
biofilm obtained from 4 sets experiments in triplicate (n=12) is 
presented in a bar graph. * indicates significant differences in 
mean percentages were compared to the untreated control 
(p<0.001) according to the non-parametric Kruskal Wallis test 
with Mann Whitney.Different letters indicate statistically 
significant differences between groups. 
4. Discussions  
In our study, the antimicrobial activity (MIC and MBC) 
of M. alba leaf extract was tested against S. mutans. The 
M. alba leaves extract was found to exhibit antibacterial 
activity against S. mutans. with MBC 50mg/mL, and 
MIC was 25mg/mL.  Our finding indicated that the M. 
alba leaves extracts exhibited antimicrobial activity and 
in agreement with previous study that also showed the 
similar extract inhibited the growth of pathogenic 
bacteria [17] and fungal [21]. Sharma et al, (2016) also 
*
* a * b * a 
0
20
40
60
80
3.125
mg/ml
6.25
mg/ml
12.5
mg/ml
0.12%
CHX
A
d
h
e
re
n
c
e
 
in
h
ib
it
io
n
 
p
e
rc
e
n
ta
g
e
 (
%
)
Test
* 
a
*
b
*
b
0
20
40
60
3.125
mg/ml
6.25
mg/ml
12.5
mg/ml
0.12%
CHX
B
io
fi
lm
 e
ra
d
ic
a
ti
o
n
 
p
e
rc
e
n
ta
g
e
s
 (
%
)
Test
Volume 1 | 2019   PROCEEDING BOOK OF
 9TH DENTAL STUDENTS’ SCIENTIFIC SYMPOSIUM 
 
24 
reported the antimicrobial effectiveness of M. alba 
leaves extract against S.mutans with MIC of 
2.5mg/10mL [12]. 
Another study was conducted where it provided 
evidence that the M. alba leaves extracts also showed an 
anticariogenic potential based on bacteriostatic effects 
and biofilm of S. mutans [16]. However their study was 
different from our study because the extract was 
incubated with the bacteria for 24 hours. In our study the 
the base of wells (represent tooth) was exposed to the 
extract for 5 minutes to mimic the use of oral rinse 
followed by addition of bacterial culture.  
A number of previous studies reported that M. alba 
contains beneficial phytocompound such as 
chalcomoracin, moracin C, 1-deoxynojirimycin (DNJ), 
morin, kuwanon G and oxyresveratrol [14, 16, 22-24]. 
Inhibition of biofilm formation can be explained by the 
presence of 1-deoxynojirimycin (DNJ) in M. alba, which 
is previously reported by Islam et al, 2008 that DNJ 
could be a promising compound for targeting biofilms of 
S.mutans [16].Another study also shows the efficacy of 
morin isolated from M. alba as it depicts antibacterial 
activities by using paper disc diffusion method. It was 
found to be useful for managing populations of oral 
bacteria although growth inhibiting for morin was 
slightly lower than that of chlorhexidine [23]. 
Our findings are in agreement with other published 
works which shows that M. alba can inhibit and 
eradicate biofilm of S. mutans. This study highlight that 
M. alba demonstrate antibiofilm properties which might 
be an adjunctive for another antibiofilm therapy. 
5. Conclusion 
As conclusion, the result suggests that M. alba leaves 
extract represents an untapped source of the local plant 
with antimicrobial and  antibiofilm activity against 
S.mutans that could be a resource in the development of 
therapeutic natural products in managing dental caries. 
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